Evolus Strives for Substantial Growth with $700m Franchise Revenue Target by 2028
Wednesday, 20 March 2024, 18:05
Evolus: Smooth Progress As Management Targets $700m Aesthetics Franchise Revenues By 2028
Evolus management has guided for over $250m revenues in 2024, and Jeuveau launch bodes well. Learn why I find EOLS stock to be a relatively straightforward Buy.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.